bluebird bio Inc. (NASDAQ: BLUE) stock closed at 4.4 per share at the end of the most recent trading day (a 2.8% change compared to the prior day closing price) with a volume of 7.66M shares and market capitalization of 314.39M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 1213 people. bluebird bio Inc. CEO is Nick Leschly.

The one-year performance of bluebird bio Inc. stock is -86.76%, while year-to-date (YTD) performance is -55.96%. BLUE stock has a five-year performance of -96.07%. Its 52-week range is between 2.865 and 33.09, which gives BLUE stock a 52-week price range ratio of 5.08%

bluebird bio Inc. currently has a PE ratio of -0.40, a price-to-book (PB) ratio of 1.01, a price-to-sale (PS) ratio of -42.45, a price to cashflow ratio of 5.70, a PEG ratio of 2.32, a ROA of -72.23%, a ROC of -82.72% and a ROE of -105.35%. The company’s profit margin is -%, its EBITDA margin is -11 119.40%, and its revenue ttm is $-7 187 000.00 , which makes it $-0.10 revenue per share.

Of the last four earnings reports from bluebird bio Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-1.28 for the next earnings report. bluebird bio Inc.’s next earnings report date is 08th Aug 2022.

The consensus rating of Wall Street analysts for bluebird bio Inc. is Hold (3.24), with a target price of $12.89, which is +192.96% compared to the current price. The earnings rating for bluebird bio Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

bluebird bio Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

bluebird bio Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 22.28, ATR14 : 0.59, CCI20 : 110.92, Chaikin Money Flow : -0.29, MACD : 0.16, Money Flow Index : 79.50, ROC : 39.24, RSI : 59.25, STOCH (14,3) : 46.48, STOCH RSI : 0.92, UO : 53.18, Williams %R : -53.52), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of bluebird bio Inc. in the last 12-months were: Andrew Obenshain (Sold 8 557 shares of value $82 093 ), Douglas G. Cole (Sold 9 942 shares of value $95 105 ), Jessica Whitten (Sold 3 393 shares of value $35 056 ), Nick Leschly (Sold 7 437 shares of value $71 143 ), Thomas J. Klima (Sold 3 753 shares of value $11 535 )